Nalaganje...
Business models and opportunities for cancer vaccine developers
Despite of growing oncology pipeline, cancer vaccines contribute only to a minor share of total oncology-attributed revenues. This is mainly because of a limited number of approved products and limited sales from products approved under compassionate or via early access entry in smaller and less dev...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Landes Bioscience
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3660762/ https://ncbi.nlm.nih.gov/pubmed/22894953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.20629 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|